Sign In
Buy IUGNF
$0.0950
+0 (+0%)
At Close: Jun 22, 2026
FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI
06:38am, Friday, 12'th Jun 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week announced that the US Food and Drug Administration (FDA) granted Fast Track Designation to its...
Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions
10:32am, Tuesday, 09'th Jun 2026
CAR T therapies have transformed treatment options for some blood cancers. They have also exposed one of cell therapy's biggest practical limitations: time....
Thor Energy lifted by hydrogen project update
06:14am, Tuesday, 09'th Jun 2026
Thor Energy PLC (AIM:THR, OTCQB:THORF, ASX:THR) shares lifted 25%, to 0.75p, after it said Phase-2 survey work at its HY-Range project in South Australia...
Imugene showcases Azer-Cel progress at ASCO - ICYMI
07:07am, Friday, 05'th Jun 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week highlighted encouraging clinical progress for its Azer-Cel program after presenting new data at...
Dow Jones, Nasdaq close at record levels as Trump says US-Iran peace talks are advancing
12:15pm, Monday, 01'st Jun 2026
4:15pm: Peace optimism boosts stocks US stocks finished Monday’s session higher on renewed hopes a peace deal would be struck between the US and Iran, with...
Costco's value strategy, membership growth support outlook after strong quarter, says Jefferies
12:08pm, Monday, 01'st Jun 2026
Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) delivered a strong fiscal third quarter performance, with its value-focused strategy, membership...
Anthropic confidentially files to go public in the US
09:12am, Monday, 01'st Jun 2026
Anthropic said on Monday it has confidentially filed for a US initial public offering, positioning the artificial intelligence company for what could become...
Iovance Biotherapeutics pushes cell therapy platform into solid tumor market
08:29am, Monday, 01'st Jun 2026
Iovance Biotherapeutics (NASDAQ:IOVA) said it has obtained clearance of an Investigational New Drug application for IOV-5001, extending its next-generation...
Small Cap Watch: commercial expansion updates drive news flow
06:02am, Monday, 01'st Jun 2026
The S&P/ASX Small Ordinaries Index continued its strong run, climbing 2.28% on Friday to close at 3,501.80 and gaining 2.19% over the past five trading...
Imugene presents azer-cel data at ASCO as trial expands into new cohort
05:50am, Monday, 01'st Jun 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has presented new Phase 1b data for its azer-cel cell therapy at the 2026 American Society of Clinical Oncology...
Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI
06:50am, Friday, 29'th May 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) recently highlighted encouraging new clinical data for its allogeneic CAR-T therapy Azer-Cel, while also...
Costco reports strong sales growth in fiscal third quarter
12:41pm, Thursday, 28'th May 2026
Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) reported fiscal third quarter financial results that topped Wall Street expectations, though shares...
Imugene doses first patient in BTKi combination cohort for azer-cel study
07:14am, Thursday, 28'th May 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has dosed the first patient in the Bruton Tyrosine Kinase inhibitor (BTKi) combination cohort of its Phase 1b...
Imugene strengthens board with biotech and pharma appointments
07:29am, Tuesday, 26'th May 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has appointed Dr Charmaine Gittleson and Michael Kotsanis as non-executive directors as part of a board...
IBM shares extend rally as Wedbush calls US quantum investment a "new catalyst"
08:20am, Friday, 22'nd May 2026
International Business Machines Corp (NYSE:IBM) shares are on track to close the week nearly 18% higher after the US Department of Commerce's $2 billion...
